| 发明名称 |
ANTI-MEASLES CANCER IMMUNOTHERAPY |
| 摘要 |
The present invention provides methods for treating specific populations of cancer patients by immunotherapy. The methods comprise administering an immunogenic composition eliciting an immune response to measles virus to patients having measles virus-immunoreactive cancer cells. |
| 申请公布号 |
US2016103130(A1) |
申请公布日期 |
2016.04.14 |
| 申请号 |
US201514881728 |
申请日期 |
2015.10.13 |
| 申请人 |
MOR RESEARCH APPLICATIONS LTD. |
发明人 |
ARIAD Shmuel;GOPAS Jacob;BENHARROCH Daniel;LAZAREV Irina |
| 分类号 |
G01N33/574;A61N5/10;A61K45/06;A61K39/165;C12N7/00 |
主分类号 |
G01N33/574 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating cancer in a patient in need thereof, the method comprising:
a) testing cancer cells of the patient using a measles virus immunoassay, b) detecting the presence of measles virus-immunoreactive cancer cells, c) if the patient is determined to have measles virus-immunoreactive cancer cells, administering an immunogenic composition that elicits an immune response to measles virus to the patient. |
| 地址 |
Tel-Aviv IL |
